Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Garvan Institute of Medical Research, New South Wales, Australia
School of Medical Sciences, University of New South Wales, New South Wales, Australia
Search for other papers by Vita Birzniece in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Department of Diabetes and Endocrinology, Westmead Hospital, New South Wales, Australia
Search for other papers by Teresa Lam in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Mark McLean in
Google Scholar
PubMed
Search for other papers by Navneeta Reddy in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Haleh Shahidipour in
Google Scholar
PubMed
Faculty of Medicine, Health and Human Sciences, Macquarie University, New South Wales, Australia
Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia
Search for other papers by Amy Hayden in
Google Scholar
PubMed
Search for other papers by Howard Gurney in
Google Scholar
PubMed
Search for other papers by Glenn Stone in
Google Scholar
PubMed
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Steno Diabetes Center Odense, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Rikke Hjortebjerg in
Google Scholar
PubMed
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Jan Frystyk in
Google Scholar
PubMed
hypogonadism, it is associated with the development of obesity, insulin resistance, hyperinsulinemia, and increased cardiovascular disease risk ( 1 , 2 ). The metabolic syndrome is present in >50% of men receiving long-term ADT compared to 20% of matched
Division of General Medicine, Istituto Auxologico Italiano, IRCCS, S. Giuseppe Hospital, Piancavallo di Oggebbio (VB), Italy
Search for other papers by Chiara Mele in
Google Scholar
PubMed
Search for other papers by Maria Teresa Samà in
Google Scholar
PubMed
Search for other papers by Alessandro Angelo Bisoffi in
Google Scholar
PubMed
Search for other papers by Marina Caputo in
Google Scholar
PubMed
Search for other papers by Valentina Bullara in
Google Scholar
PubMed
Search for other papers by Stefania Mai in
Google Scholar
PubMed
Search for other papers by Gillian Elisabeth Walker in
Google Scholar
PubMed
Search for other papers by Flavia Prodam in
Google Scholar
PubMed
Division of General Medicine, Istituto Auxologico Italiano, IRCCS, S. Giuseppe Hospital, Piancavallo di Oggebbio (VB), Italy
Search for other papers by Paolo Marzullo in
Google Scholar
PubMed
Search for other papers by Gianluca Aimaretti in
Google Scholar
PubMed
Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy
Search for other papers by Loredana Pagano in
Google Scholar
PubMed
-sectional studies and confirmed in meta-analyses of cross-sectional and prospective studies. Many advocate that environmental and lifestyle factors, such as obesity and insulin resistance (IR), could be implicated in the pathogenesis of thyroid cancer ( 2 , 9 , 10
Search for other papers by Ling Hu in
Google Scholar
PubMed
Search for other papers by Ting Li in
Google Scholar
PubMed
Search for other papers by Xiao-Ling Yin in
Google Scholar
PubMed
Search for other papers by Yi Zou in
Google Scholar
PubMed
the increase in the incidence of TN is related to some components of MS ( 7 ). Researchers in the field have found that MS and insulin resistance are important factors associated with the increased incidence of nodular goiter and thyroid cancer ( 8
Search for other papers by Stephen J Winters in
Google Scholar
PubMed
Search for other papers by Charles R Scoggins in
Google Scholar
PubMed
Search for other papers by Duke Appiah in
Google Scholar
PubMed
Search for other papers by Dushan T Ghooray in
Google Scholar
PubMed
foregoing patients in order to better understand the relationship between insulin, insulin resistance by HOMA, and hepatic long chain fatty acids and the expression of HNF4α and SHBG in human liver. We hypothesized that both insulin resistance and total
Search for other papers by Hong-Fa Yan in
Google Scholar
PubMed
Search for other papers by Zhao-Yu Liu in
Google Scholar
PubMed
Search for other papers by Zhi-Ang Guan in
Google Scholar
PubMed
Search for other papers by Chuang Guo in
Google Scholar
PubMed
Introduction Type 2 diabetes mellitus (T2DM) is becoming one of the most pressing health issues facing society. Although T2DM is well described in terms of its hallmarks, namely insulin resistance and chronic hyperglycemia, the factors
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed
Search for other papers by Marilena Giannoudi in
Google Scholar
PubMed
Search for other papers by Satish S Kumar in
Google Scholar
PubMed
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Khyatisha Seejore in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Harpal Randeva in
Google Scholar
PubMed
Leeds Institute of Medical Research, University of Leeds, UK
Search for other papers by Adam Glaser in
Google Scholar
PubMed
Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed
Search for other papers by Georgina Gerrard in
Google Scholar
PubMed
Search for other papers by Carmel Loughrey in
Google Scholar
PubMed
Search for other papers by Ahmed Al-Qaissi in
Google Scholar
PubMed
Search for other papers by Ramzi Ajjan in
Google Scholar
PubMed
Search for other papers by Julie Lynch in
Google Scholar
PubMed
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Robert D Murray in
Google Scholar
PubMed
model assessment for insulin resistance (HOMA) equation (fasting plasma glucose (mmol/L) × fasting serum insulin (mU/L) divided by 22.5). The prevalence of metabolic syndrome was determined according to the International Diabetes Federation criteria ( 10
Search for other papers by Yao Su in
Google Scholar
PubMed
Search for other papers by Li Chen in
Google Scholar
PubMed
Search for other papers by Dong-Yao Zhang in
Google Scholar
PubMed
Search for other papers by Xu-Pei Gan in
Google Scholar
PubMed
Search for other papers by Yan-Nan Cao in
Google Scholar
PubMed
Search for other papers by De-Cui Cheng in
Google Scholar
PubMed
Search for other papers by Wen-Yu Liu in
Google Scholar
PubMed
Search for other papers by Fei-Fei Li in
Google Scholar
PubMed
Search for other papers by Xian-Ming Xu in
Google Scholar
PubMed
Search for other papers by Hong-Kun Wang in
Google Scholar
PubMed
short-term health of the mother and the child. However, the etiology of GDM remains unclear. It may be caused by insulin resistance and pancreatic β-cell secretion defects caused by genetic and environmental factors, but recent studies have revealed that
Search for other papers by Nikolaj Rittig in
Google Scholar
PubMed
Search for other papers by Mads Svart in
Google Scholar
PubMed
Search for other papers by Niels Jessen in
Google Scholar
PubMed
Search for other papers by Niels Møller in
Google Scholar
PubMed
Search for other papers by Holger J Møller in
Google Scholar
PubMed
Search for other papers by Henning Grønbæk in
Google Scholar
PubMed
as obesity, sepsis, insulin resistance, diabetes mellitus type 2 (DM2) and non-alcoholic fatty liver disease (NAFLD) ( 1 , 2 , 3 , 4 , 5 , 6 ). These diseases are also associated with changes in the lipid metabolism, accelerated lipolysis and
Search for other papers by Angela Köninger in
Google Scholar
PubMed
Search for other papers by Philippos Edimiris in
Google Scholar
PubMed
Search for other papers by Laura Koch in
Google Scholar
PubMed
Search for other papers by Antje Enekwe in
Google Scholar
PubMed
Search for other papers by Claudia Lamina in
Google Scholar
PubMed
Search for other papers by Sabine Kasimir-Bauer in
Google Scholar
PubMed
Search for other papers by Rainer Kimmig in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, Division of Genetic Epidemiology, Vitateq Biotechnology GmbH, University of Duisburg-Essen, D-45122 Essen, Germany
Search for other papers by Hans Dieplinger in
Google Scholar
PubMed
parameters of oxidative stress such as ‘advanced glycosylation end products’ correlated strongly with anovulation, follicle number, and concentrations of anti-Müllerian hormone (AMH) in patients with PCOS (3) . Although insulin resistance (IR) plays an
Search for other papers by Yuka Goto in
Google Scholar
PubMed
Search for other papers by Yoshie Otsuka in
Google Scholar
PubMed
Search for other papers by Kenji Ashida in
Google Scholar
PubMed
Search for other papers by Ayako Nagayama in
Google Scholar
PubMed
Search for other papers by Nao Hasuzawa in
Google Scholar
PubMed
Search for other papers by Shimpei Iwata in
Google Scholar
PubMed
Search for other papers by Kento Hara in
Google Scholar
PubMed
Search for other papers by Munehisa Tsuruta in
Google Scholar
PubMed
Search for other papers by Nobuhiko Wada in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Diabetes Center, Kurume Medical Center, Kokubu-machi, Kurume-city, Fukuoka, Japan
Search for other papers by Seiichi Motomura in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Diabetes Center, Kurume Medical Center, Kokubu-machi, Kurume-city, Fukuoka, Japan
Search for other papers by Yuji Tajiri in
Google Scholar
PubMed
Search for other papers by Masatoshi Nomura in
Google Scholar
PubMed
inhibition of hypoglycemia are required to prevent macrovascular complications ( 1 , 10 , 11 ). In an animal model, SGLT2 inhibitors exerted amelioration effects against insulin resistance by reducing ectopic fat volume ( 12 , 13 ) and increasing the